Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Aberrant mRNA ribosome loading and translation negatively affects hematopoiesis in Shwachman-Diamond Syndrome with DNAJC21 biallelic mutations.

FY 2023-24

Summary
Shwachman-Diamond Syndrome (SDS) is a bone marrow failure syndrome where the bone marrow stem cells (which give rise to all types of blood cells) do not function properly. This negatively affects the bones, pancreas, overall growth, and the brain. In this project, I am investigating how a novel mutation in the DNAJC21 gene causes lower DNAJC21 protein levels, resulting in SDS. DNAJC21 normally promotes protein production in cells by influencing the ribosomes (which translate gene mRNA ‘instructions’ into proteins). I will collect ribosomes and associated mRNAs from the human K562 and TF1 cell lines (these represent early cell types in the blood development process), and will analyze the amounts and types of mRNAs present. Cell lines will be used as these experiments require large amounts of cells (~60 million), which cannot be obtained from patients. This data will be compared to the protein types and abundances in these cells to identify which mRNA/protein pairs are significantly dysregulated due to reduced levels of DNAJC21. Finally, I will obtain data regarding protein types and abundance from limited patient bone marrow samples to ensure our cell line findings accurately represent how the disease affects SDS patients. We will then investigate whether altering the levels of these proteins alleviates disease symptoms in cell lines. This study will be the first to investigate how DNAJC21 is involved in SDS disease occurrence. The gene/protein pairs highlighted could be investigated as future therapeutic targets, which are urgently required as the current stem cell transplant therapy is grossly inefficient. Future studies involving other novel SDS-related mutations and other similar syndromes could use this project as a guide to structure their research approach.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506157
Name
Kanade Shreya
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Aberrant mRNA ribosome loading and translation negatively affects hematopoiesis in Shwachman-Diamond Syndrome with DNAJC21 biallelic mutations.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aberrant Ribosome Biogenesis; Abnormal Mrna Loading Onto Ribosomes; Abnormal Mrna Translation; Genetic Hematopoiesis Disruption; Hematopoietic Stem Cell Differentiation Failure; Inherited Bone Marrow Failure Syndrome; Leukemia Predisposition; Novel Mutation; Novel Pathogenesis Mechanism; Schwachman-Diamond Syndrome
Abstract
Shwachman-Diamond Syndrome (SDS) is a bone marrow failure syndrome where the bone marrow stem cells (which give rise to all types of blood cells) do not function properly. This negatively affects the bones, pancreas, overall growth, and the brain. In this project, I am investigating how a novel mutation in the DNAJC21 gene causes lower DNAJC21 protein levels, resulting in SDS. DNAJC21 normally promotes protein production in cells by influencing the ribosomes (which translate gene mRNA ‘instructions’ into proteins). I will collect ribosomes and associated mRNAs from the human K562 and TF1 cell lines (these represent early cell types in the blood development process), and will analyze the amounts and types of mRNAs present. Cell lines will be used as these experiments require large amounts of cells (~60 million), which cannot be obtained from patients. This data will be compared to the protein types and abundances in these cells to identify which mRNA/protein pairs are significantly dysregulated due to reduced levels of DNAJC21. Finally, I will obtain data regarding protein types and abundance from limited patient bone marrow samples to ensure our cell line findings accurately represent how the disease affects SDS patients. We will then investigate whether altering the levels of these proteins alleviates disease symptoms in cell lines. This study will be the first to investigate how DNAJC21 is involved in SDS disease occurrence. The gene/protein pairs highlighted could be investigated as future therapeutic targets, which are urgently required as the current stem cell transplant therapy is grossly inefficient. Future studies involving other novel SDS-related mutations and other similar syndromes could use this project as a guide to structure their research approach.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kanade, Shreya
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~